Genomic Valley Biotech informs about disclosure

13 May 2022 Evaluate

Genomic Valley Biotech has confirmed that the company do not fall under the ambit of 'Large Entities' as per the SEBI Circular No. SEBI/HO/DDHS/CIR/P/2018/144 regarding the Fund raising of Debt Securities by Large Entities and do not have an outstanding long-term borrowing of Rs 100 crores or above with original maturity of more than one year.

The above information is a part of company’s filings submitted to BSE.

Genomic Valley Share Price

26.00 0.14 (0.54%)
07-Jan-2026 10:58 View Price Chart
Peers
Company Name CMP
Venkys India 1564.00
Mangalam Global Ent 14.12
Kaveri Seed 943.00
Regaal Resources 72.93
Simran Farms 171.55
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×